Company Filing History:
Years Active: 2025
Title: The Innovations of Lai Ling Sharon Chan
Introduction
Lai Ling Sharon Chan is a notable inventor based in Singapore, SG. He has made significant contributions to the field of medical research, particularly in the area of neurodegenerative diseases. His work focuses on the inhibition of LRRK2 kinase, which is associated with conditions such as Parkinson's disease.
Latest Patents
Lai Ling Sharon Chan holds a patent titled "THREONINE166 and SERINE189 of rubicon run domain as LRRK2 kinase inhibition target sites." This patent outlines a method for detecting phosphorylation at Threonine 166 of a Rubicon protein. The invention aims to identify subjects with diseases linked to LRRK2, including Parkinson's disease, and provides insights into compounds and methods for treatment. He has 1 patent to his name.
Career Highlights
Chan is currently employed at Singapore Health Services Pte Ltd, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on understanding and treating neurodegenerative diseases.
Collaborations
His coworker, Eng King Tan, has been a part of his professional journey, contributing to the collaborative efforts in their research endeavors.
Conclusion
Lai Ling Sharon Chan's innovative work in the field of medical research highlights the importance of targeting LRRK2 kinase in the fight against Parkinson's disease. His contributions are paving the way for future advancements in treatment options.